Orion Oyj logo

Orion Oyj

HEL:ORNBV.HE

Overview | Financials
Company Name Orion Oyj
Symbol ORNBV.HE
Currency EUR
Price 37.63
Market Cap 5,281,746,499
Dividend Yield 2.15%
52-week-range 32.89 - 55.16
Industry Drug Manufacturers—General
Sector Healthcare
CEO Dr. Liisa Hurme
Website https://www.orion.fi

An error occurred while fetching data.

About Orion Oyj

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, other European countries, North America, and internationally. It provides prescription drugs and self-care products, including Nubeqa for the treatment of prostate cancer; dexdor and Precedex for intensive care sedative; Stalevo and Comtess/Comtan

Related Stocks

Terveystalo Oyj logo

Terveystalo Oyj

TTALO.HE

7.12 EUR

Revenio Group Oyj logo

Revenio Group Oyj

REG1V.HE

24.12 EUR

Oriola Oyj logo

Oriola Oyj

OKDBV.HE

1.044 EUR

Nanoform Finland Oyj logo

Nanoform Finland Oyj

NANOFH.HE

1.68 EUR

Pihlajalinna Oyj logo

Pihlajalinna Oyj

PIHLIS.HE

7.75 EUR

Modulight Oyj logo

Modulight Oyj

MODU.HE

1.218 EUR

Optomed Oyj logo

Optomed Oyj

OPTOMED.HE

3.16 EUR

Nexstim Plc logo

Nexstim Plc

NXTMH.HE

2.4 EUR

Biohit Oyj logo

Biohit Oyj

BIOBV.HE

1.95 EUR

Herantis Pharma Oyj logo

Herantis Pharma Oyj

HRTIS.HE

1.69 EUR

Financials

Numbers are in millions USD

Numbers are in millions USD